Home > Journals > Gazzetta Medica Italiana Archivio per le Scienze Mediche > Past Issues > Gazzetta Medica Italiana Archivio per le Scienze Mediche 2011 August;170(4) > Gazzetta Medica Italiana Archivio per le Scienze Mediche 2011 August;170(4):259-62

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe PROMO
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Reprints

 

REVIEWS   

Gazzetta Medica Italiana Archivio per le Scienze Mediche 2011 August;170(4):259-62

Copyright © 2011 EDIZIONI MINERVA MEDICA

language: Italian

Aliskiren and renin-angiotension system inhibition

Incardona V. M., Dato E., Dato A. G.

Centro di Diagnostica Cardiovascolare del Dott. Dato Achille Giuseppe & C. Sas, Paternò, Catania, Italia


PDF


The renin-angiotension system inhibition is a very efficacious pharmacological approach in control of cardiovascular and renal diseases. Aliskiren is a direct inhibitor of rennin and clinical trials prove a good control of blood pressure and protective effect in cardiovascular and renal diseases. After the promising results obtained, future clinical trials asses and confirm the organ-protective effects of aliskiren in the vascular diseases.

top of page